Skip to content

Kinetic Defects in Lipoprotein Metabolism in Patients with Renal Failure

Kinetic Defects in Lipoprotein Metabolism in Patients with Renal Failure

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12605000726651
Enrollment
40
Registered
2005-11-11
Start date
2006-03-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Nil.

Sponsors

Cardiovascular Lipid Research Grant Pfizer
Lead SponsorCommercial sector/Industry

Eligibility

Sex/Gender
All
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Non-diabetic CRF (GFR 40-60 ml/min) and 20 age, sex and weight matched healthy controls.

Exclusion criteria

Type 1 or 2 Diabetes mellitus; Nephrotic Syndrome; Renal Replacement Therapy; BMI > 35 kg/m2; On lipid-modifying therapy; Alcohol consumption > 3 standard drinks / day; Liver disease; Primary dyslipidaemia (familial hypercholesterolaemia or familial combined hyperlipidaemia) or non-uraemia related secondary dyslipidaemia; Untreated thyroid disease; Significant psychiatric disorder; Cyclical hormone therapy in females.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026